Ifp Advisors, Inc Biotechnology

Ifp Advisors, Inc

$3.28 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ACLX Arcellx, Inc.	$3.06B	$0 0.0% of portfolio	0	Q2 2025 New
RCUS Arcus Biosciences, Inc.	$780M	$0 0.0% of portfolio	0	Q2 2025 New
ARCT Arcturus Therapeutics Holdings Inc.	$444M	$0 0.0% of portfolio	0	Q2 2025 New
ATXS Astria Therapeutics, Inc.	$98.7M	$0 0.0% of portfolio	0	Q2 2025 New
AVIR Atea Pharmaceuticals, Inc.	$283M	$0 0.0% of portfolio	0	Q2 2025 New
AURA Aura Biosciences, Inc.	$185M	$0 0.0% of portfolio	0	Q2 2025 Sold Out
BEAM Beam Therapeutics Inc.	$1.3B	$0 0.0% of portfolio	0	Q2 2025 New
BMEA Biomea Fusion, Inc.	$59.5M	$0 0.0% of portfolio	116	Q2 2025 New
CCCC C4 Therapeutics, Inc.	$123M	$0 0.0% of portfolio	34	Q2 2025 New
CAPR Capricor Therapeutics, Inc.	$154M	$0 0.0% of portfolio	0	Q2 2025 New
CRDF Cardiff Oncology, Inc.	$89.3M	$0 0.0% of portfolio	0	Q2 2025 New
CRBU Caribou Biosciences, Inc.	$114M	$0 0.0% of portfolio	145	Q2 2025 Added 253.66%
SAVA Cassava Sciences Inc	$91M	$0 0.0% of portfolio	10	Q2 2025 Reduced 33.33%
CELC Celcuity Inc.	$783M	$0 0.0% of portfolio	0	Q2 2025 New
CLDX Celldex Therapeutics, Inc.	$1.03B	$0 0.0% of portfolio	0	Q2 2025 New
IPSC Century Therapeutics, Inc.	$28.3M	$0 0.0% of portfolio	6	Q2 2025 New
COGT Cogent Biosciences, Inc.	$789M	$0 0.0% of portfolio	0	Q2 2025 Sold Out
CHRS Coherus Bio Sciences, Inc.	$92.5M	$0 0.0% of portfolio	377	Q2 2025 Added 68.3%
CRMD Cor Medix Inc.	$597M	$0 0.0% of portfolio	9	Q2 2025 New
CUE Cue Biopharma, Inc.	$28.3M	$0 0.0% of portfolio	100	Q4 2023 New
CGEM Cullinan Oncology, Inc.	$342M	$0 0.0% of portfolio	0	Q2 2025 New
DAWN Day One Biopharmaceuticals, Inc.	$544M	$0 0.0% of portfolio	58	Q2 2025 Added 141.67%
DNLI Denali Therapeutics Inc.	$2.07B	$0 0.0% of portfolio	0	Q2 2025 New
DSGN Design Therapeutics, Inc.	$320M	$0 0.0% of portfolio	0	Q2 2025 New
DYN Dyne Therapeutics, Inc.	$699M	$0 0.0% of portfolio	0	Q2 2025 New
EWTX Edgewise Therapeutics, Inc.	$939M	$0 0.0% of portfolio	0	Q2 2025 New
ETNB 89bio, Inc.	$417M	$0 0.0% of portfolio	0	Q2 2025 New
TRDA Entrada Therapeutics, Inc.	$164M	$0 0.0% of portfolio	0	Q2 2025 Sold Out
ERAS Erasca, Inc.	$195M	$0 0.0% of portfolio	86	Q2 2025 New
EYPT Eye Point Pharmaceuticals, Inc.	$400M	$0 0.0% of portfolio	0	Q2 2025 New
FATE Fate Therapeutics Inc	$99.9M	$0 0.0% of portfolio	85	Q2 2025 New
FHTX Foghorn Therapeutics Inc.	$220M	$0 0.0% of portfolio	0	Q2 2025 Sold Out
FDMT 4 D Molecular Therapeutics, Inc.	$202M	$0 0.0% of portfolio	0	Q2 2025 New
GERN Geron Corp	$555M	$0 0.0% of portfolio	55	Q2 2025 New
HRTX Heron Therapeutics, Inc.	$157M	$0 0.0% of portfolio	34	Q2 2025 New
IMNM Immunome Inc.	$114M	$0 0.0% of portfolio	6	Q2 2025 New
IMVT Immunovant, Inc.	$3.55B	$0 0.0% of portfolio	0	Q2 2025 New
INVA Innoviva, Inc.	$1.46B	$0 0.0% of portfolio	0	Q2 2025 New
INMB Inmune Bio, Inc.	$37M	$0 0.0% of portfolio	184	Q1 2023 Reduced 50.0%
INZY Inozyme Pharma, Inc.	$161M	$0 0.0% of portfolio	0	Q2 2025 Sold Out
NTLA Intellia Therapeutics, Inc.	$867M	$0 0.0% of portfolio	0	Q2 2025 Sold Out
IOVA Iovance Biotherapeutics, Inc.	$346M	$0 0.0% of portfolio	88	Q2 2025 New
KALV Kal Vista Pharmaceuticals, Inc.	$350M	$0 0.0% of portfolio	0	Q2 2025 Sold Out
KMPH Kempharm, Inc	$170M	$0 0.0% of portfolio	0	Q2 2025 New
KROS Keros Therapeutics, Inc.	$405M	$0 0.0% of portfolio	1	Q2 2025 New
KOD Kodiak Sciences Inc.	$449M	$0 0.0% of portfolio	0	Q2 2025 New
LRMR Larimar Therapeutics, Inc.	$164M	$0 0.0% of portfolio	85	Q2 2025 New
LXRX Lexicon Pharmaceuticals, Inc.	$211M	$0 0.0% of portfolio	1	Q2 2025 New
LQDA Liquidia Corp	$1.84B	$0 0.0% of portfolio	0	Q2 2025 New
LYEL Lyell Immunopharma, Inc.	$2.83B	$0 0.0% of portfolio	63	Q2 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.